Stage 1 to 3 CKM syndrome linked to significantly higher mean-mean, mean-maximum carotid intima-medial thickness
TUESDAY, Sept. 8, 2026 (HealthDay News) — For young adults, more advanced cardiovascular-kidney-metabolic (CKM) syndrome is associated with worse cardiovascular health, according to a study published online Aug. 20 in Circulation: Population Health and Outcomes.
Vaishnavi Krishnan, from the Boston University Chobanian & Avedisian School of Medicine, and colleagues examined how the CKM staging construct applies to young adults. CKM stages were defined in the Future of Families-Cardiovascular Health Among Young Adults (FF-CHAYA) study. Cardiovascular health was measured using Life”s Essential 8 scores, and the cross-sectional associations of CKM stages with Life”s Essential 8 scores and carotid ultrasonography measures were examined.
Of the 1,283 FF-CHAYA participants, 20.7, 40.2, 36.2, and 2.8 percent were classified as stage 0 CKM (no risk factors), stage 1 CKM (excess adiposity), stage 2 CKM (metabolic risk factors), and stage 3 CKM (subclinical cardiovascular disease or advanced kidney disease), respectively. The researchers found that participants in stages 1 to 3 had significantly lower Life”s Essential 8 scores than those in stage 0 (β = −7.6, −13.9, and −13.2 for stages 1, 2, and 3, respectively). Compared with stage 0, stages 1 to 3 also had significantly higher mean-mean and mean-maximum carotid intima-medial thickness and lower gray scale median. For example, mean-maximum carotid intima-medial thickness was 0.014, 0.020, and 0.100 mm higher for stages 1, 2, and 3, respectively.
“In my practice, and what I would recommend, is that the conversation focuses on Life”s Essential 8 and optimizing as many of those metrics as possible for better health today and long term,” coauthor Donald M. Lloyd-Jones, M.D., Sc.M., also from the Boston University Chobanian & Avedisian School of Medicine, said in a statement.
Pregnancy Complications Linked to Subsequent Risk for Cardiometabolic-Renal Conditions
GLP-1 Receptor Agonists, SGLT-2is Slow Renal Function Decline in T2D With Albuminuria
1997 to 2022 Saw Increase in Pediatric Hospitalizations With AKI
Early Complications Common in Older Kidney Transplant Recipients
Implant, Patient Survival Do Not Differ for Robotic and Conventional Total Joint Replacement
Physical Therapist-Supervised Exercise Improves Outcomes After ACL Reconstruction
Frailty Linked to Incident Cognitive Decline in Men With CKD
PET/MRI Offers Diagnostic, Prognostic Value in Pediatric Epilepsy